PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1538631
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1538631
Global Drug Eluting Balloons Market Size Study, by Product, by Technology, by End-user and Regional Forecasts 2024-2032
The Global Drug Eluting Balloons Market is valued approximately at USD 615.23 Million in 2023 and is anticipated to grow with a healthy growth rate of more than 7.72% over the forecast period 2024-2032. Drug-eluting balloons (DEBs) are medical devices used in the treatment of vascular diseases, particularly in the context of angioplasty for peripheral and coronary artery disease. They combine the functions of a balloon catheter with drug delivery to improve outcomes in angioplasty procedures. The market is being driven by the increasing prevalence of coronary artery disease and diabetes, which are leading causes of the rising demand for advanced therapeutic interventions. Drug-eluting balloons are pivotal in the treatment of coronary artery disease, offering a less invasive option compared to traditional stents and surgeries.
The increasing incidence of cardiovascular diseases globally is a significant driver for market growth. According to the World Health Organization (WHO), coronary heart disease is a leading cause of death worldwide, claiming millions of lives annually. This high prevalence is expected to drive the demand for angioplasty and other related treatments, consequently boosting the drug-eluting balloons market. In addition, the rising prevalence of diabetes, which can lead to cardiovascular complications, is further propelling market growth. Diabetes is a significant health concern globally, with the WHO reporting millions of deaths attributed to the disease each year. For instance, the Centers for Disease Control and Prevention (CDC) reported that in 2021, approximately 537 million adults worldwide had diabetes, with numbers expected to rise. Such statistics underscore the growing need for effective cardiovascular treatments, including drug-eluting balloons, thus fostering market growth.
The Key regions considered for the global Drug Eluting Balloons market study include North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America held the dominant market share in 2023, attributed to the presence of leading manufacturers, the introduction of technologically advanced devices, and favorable reimbursement policies. The region's advanced healthcare infrastructure, high adoption rates of innovative medical technologies, and substantial investments in research and development contribute significantly to its leadership position. North America's well-established medical device industry and the presence of major healthcare companies enhance the availability and use of DEBs. Additionally, the growing prevalence of cardiovascular diseases and peripheral artery disease in the region increases the demand for effective treatment options, such as DEBs. The region's regulatory environment and supportive reimbursement policies further facilitate market growth, making North America a key player in the global DEBs market. Europe also holds a significant market share due to the high prevalence of cardiovascular diseases. Meanwhile, the Asia-Pacific region is expected to witness the fastest growth, driven by rising healthcare expenditures and increasing cases of cardiovascular diseases.
Major market players included in this report are:
- Bayer AG
- Medtronic
- B. Braun Melsungen AG
- Cook Medical, Inc.
- Boston Scientific Corporation
- Becton, Dickinson and Company
- EuroCor
- Terumo Corporation
- Koninklijke Philips N.V.
- SurModics Inc.
The detailed segments and sub-segments of the market are explained below:
By Product:
- Coronary Drug Eluting Balloon
- Peripheral Drug Eluting Balloon
- Others
By Technology:
- Paccocath
- FreePac
- TransPax
- EnduraCoat
- Others
By End-user:
- Hospitals and Ambulatory Surgery Centers
- Cath Labs
- Others
By Region:
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- RoMEA
Years considered for the study are as follows:
- Historical year - 2022
- Base year - 2023
- Forecast period - 2024 to 2032
Key Takeaways:
- Market Estimates & Forecast for 10 years from 2022 to 2032.
- Annualized revenues and regional level analysis for each market segment.
- Detailed analysis of geographical landscape with Country level analysis of major regions.
- Competitive landscape with information on major players in the market.
- Analysis of key business strategies and recommendations on future market approach.
- Analysis of competitive structure of the market.
- Demand side and supply side analysis of the market.
Table of Contents
Chapter 1. Global Drug Eluting Balloons Market Executive Summary
- 1.1. Global Drug Eluting Balloons Market Size & Forecast (2022-2032)
- 1.2. Regional Summary
- 1.3. Segmental Summary
- 1.3.1. By Product
- 1.3.2. By Technology
- 1.3.3. By End-user
- 1.4. Key Trends
- 1.5. Recession Impact
- 1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Drug Eluting Balloons Market Definition and Research Assumptions
- 2.1. Research Objective
- 2.2. Market Definition
- 2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
- 2.3.3.1. Availability
- 2.3.3.2. Infrastructure
- 2.3.3.3. Regulatory Environment
- 2.3.3.4. Market Competition
- 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
- 2.3.4.1. Regulatory frameworks
- 2.3.4.2. Technological Advancements
- 2.3.4.3. Environmental Considerations
- 2.3.4.4. Consumer Awareness & Acceptance
- 2.4. Estimation Methodology
- 2.5. Years Considered for the Study
- 2.6. Currency Conversion Rates
Chapter 3. Global Drug Eluting Balloons Market Dynamics
- 3.1. Market Drivers
- 3.1.1. Increasing Prevalence of Coronary Artery Disease
- 3.1.2. Rising Incidence of Diabetes
- 3.1.3. Favorable Reimbursement Policies
- 3.2. Market Challenges
- 3.2.1. High Cost of Drug Eluting Balloons
- 3.2.2. Regulatory Challenges
- 3.3. Market Opportunities
- 3.3.1. Technological Advancements
- 3.3.2. Emerging Markets Expansion
Chapter 4. Global Drug Eluting Balloons Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
- 4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
- 4.3. Top Investment Opportunity
- 4.4. Top Winning Strategies
- 4.5. Disruptive Trends
- 4.6. Industry Expert Perspective
- 4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Drug Eluting Balloons Market Size & Forecasts by Product 2022-2032
- 5.1. Segment Dashboard
- 5.2. Global Drug Eluting Balloons Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 5.2.1. Coronary Drug Eluting Balloon
- 5.2.2. Peripheral Drug Eluting Balloon
- 5.2.3. Others
Chapter 6. Global Drug Eluting Balloons Market Size & Forecasts by Technology 2022-2032
- 6.1. Segment Dashboard
- 6.2. Global Drug Eluting Balloons Market: Technology Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 6.2.1. Paccocath
- 6.2.2. FreePac
- 6.2.3. TransPax
- 6.2.4. EnduraCoat
- 6.2.5. Others
Chapter 7. Global Drug Eluting Balloons Market Size & Forecasts by End-user 2022-2032
- 7.1. Segment Dashboard
- 7.2. Global Drug Eluting Balloons Market: End-user Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 7.2.1. Hospitals and Ambulatory Surgery Centers
- 7.2.2. Cath Labs
- 7.2.3. Others
Chapter 8. Global Drug Eluting Balloons Market Size & Forecast by Region 2022-2032
- 8.1. North America Drug Eluting Balloons Market
- 8.1.1. U.S. Drug Eluting Balloons Market
- 8.1.1.1. Product breakdown size & forecasts, 2022-2032
- 8.1.1.2. Technology breakdown size & forecasts, 2022-2032
- 8.1.1.3. End-user breakdown size & forecasts, 2022-2032
- 8.1.2. Canada Drug Eluting Balloons Market
- 8.1.1. U.S. Drug Eluting Balloons Market
- 8.2. Europe Drug Eluting Balloons Market
- 8.2.1. U.K. Drug Eluting Balloons Market
- 8.2.2. Germany Drug Eluting Balloons Market
- 8.2.3. France Drug Eluting Balloons Market
- 8.2.4. Spain Drug Eluting Balloons Market
- 8.2.5. Italy Drug Eluting Balloons Market
- 8.2.6. Rest of Europe Drug Eluting Balloons Market
- 8.3. Asia-Pacific Drug Eluting Balloons Market
- 8.3.1. China Drug Eluting Balloons Market
- 8.3.2. India Drug Eluting Balloons Market
- 8.3.3. Japan Drug Eluting Balloons Market
- 8.3.4. Australia Drug Eluting Balloons Market
- 8.3.5. South Korea Drug Eluting Balloons Market
- 8.3.6. Rest of Asia Pacific Drug Eluting Balloons Market
- 8.4. Latin America Drug Eluting Balloons Market
- 8.4.1. Brazil Drug Eluting Balloons Market
- 8.4.2. Mexico Drug Eluting Balloons Market
- 8.4.3. Rest of Latin America Drug Eluting Balloons Market
- 8.5. Middle East & Africa Drug Eluting Balloons Market
- 8.5.1. Saudi Arabia Drug Eluting Balloons Market
- 8.5.2. South Africa Drug Eluting Balloons Market
- 8.5.3. Rest of Middle East & Africa Drug Eluting Balloons Market
Chapter 9. Competitive Intelligence
- 9.1. Key Company SWOT Analysis
- 9.2. Top Market Strategies
- 9.3. Company Profiles
- 9.3.1. Cook Medical, Inc.
- 9.3.1.1. Key Information
- 9.3.1.2. Overview
- 9.3.1.3. Financial (Subject to Data Availability)
- 9.3.1.4. Product Summary
- 9.3.1.5. Market Strategies
- 9.3.2. Boston Scientific Corporation
- 9.3.3. Becton, Dickinson and Company
- 9.3.4. EuroCor
- 9.3.5. Terumo Corporation
- 9.3.6. Koninklijke Philips N.V.
- 9.3.7. Bayer AG
- 9.3.8. Medtronic
- 9.3.9. B. Braun Melsungen AG
- 9.3.10. SurModics Inc.
- 9.3.1. Cook Medical, Inc.
Chapter 10. Research Process
- 10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
- 10.2. Research Attributes
